Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Bleeding Complication and Treatment Failure of DOAC and Its Predictions Based on Cipherome's Pharmacogenomic Technology

NCT04597593 is registered in ClinicalTrials.gov with Cipherome, Inc. as lead sponsor.

NCT NCT04597593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04597593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Bleeding Complication and Treatment Failure of DOAC and Its Predictions Based on Cipherome's Pharmacogenomic Technology
Lead sponsor
Cipherome, Inc.
Phase
Observational
Overall status
Completed
Start date
October 7, 2020
Completion date
December 30, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-related side effects and adverse reactions, iatrogenic disorder